Press Releases

– Initiated Phase 2 study of ALTO-203 in patients with MDD and anhedonia –

– Reported positive Phase 1 data with transdermal formulation of novel PDE4 inhibitor, ALTO-101; achieved significantly greater drug exposure with improved tolerability compared to oral administration –

– Patient enrollment on track across Phase 2b MDD studies for ALTO-100 and ALTO-300 –

– Strong cash position of approximately $206 million expected to support planned... (continue reading...)

Advancing 13 Carrier Awards Toward Launch Dates Commencing in Summer 2024

Entry Into New Product Markets and Europe Drive 2024 Growth Opportunities

Expanding Portfolio and Carrier Awards Boost Company's Addressable Market from $400M to $52B[*]

San Diego, California--(Newsfile Corp. - May 14, 2024) - Sonim Technologies, Inc. (NASDAQ: SONM), a leading provider of mobility solutions that include ultra-rugged and rugged phones, connected devices, consumer durable mobile... (continue reading...)

JACKSONVILLE, FL / ACCESSWIRE / May 14, 2024 / ParkerVision, Inc. (OTCQB: PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three months ended March 31, 2024.

2024 Summary and Recent Developments

• The Company is awaiting a decision from the United States Court of Appeals for the Federal Circuit (CAFC) following the November 6, 2023 oral arguments in ParkerVision v.... (continue reading...)

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter of 2024 and filed its quarterly report on Form 10-Q for the three months ended March 31, 2024 with the Securities and Exchange Commission. The Company will also hold a conference call at 4:30 PM ET today in which it... (continue reading...)

Murphy to support leadership team's initiatives to improve profitability and drive long-term growth

SAN DIEGO, May 14, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), today announced the appointment of Glenn Murphy as Executive Chairman of the Board of Directors, effective immediately.

As Executive Chairman, Murphy will... (continue reading...)